BRIEF-Allergan says FDA accepts premarket notification filing for glaucoma treatment
June 15 (Reuters) - Allergan Plc :
* "Look forward to working together with FDA" to bring glaucoma treatment system to market
* Allergan announces FDA acceptance of the 510(k) premarket notification filing for the XEN glaucoma treatment system Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.